Deferoxamine Mesylate for injection
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Most common reason: Sterility / contamination (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Deferoxamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of sterility assurance.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.